Sanofi-aventis U.s. Llc Company Profile
✉ Email this page to a colleague
Summary for Sanofi-aventis U.s. Llc
Patents: | 4 |
Tradenames: | 10 |
Ingredients: | 9 |
BLAs: | 10 |
Biologic Drugs for Sanofi-aventis U.s. Llc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | ⤷ Try a Trial | |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,370,629 | ⤷ Try a Trial |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,509,905 | ⤷ Try a Trial |
Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | 2000-04-20 | 5,656,722 | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
This search can help find similar names.